Cytokine profiles of dendritic cells (DCs) during infection with bovine leukaemia virus (BLV)

• Autorzy: Iwan E. , Szczotka M. , Kocki J.
• Języki publikacji: EN

Abstrakty

EN

BLV is an agent of enzootic bovine leukaemia (EBL), an infectious disease affecting cattle worldwide. BLV infection has been associated with immune system disorders and discrepancies in the cytokine network. The significance of dendritic cells in the pathogenesis of BLV infection is largely unknown, but considering their fundamental role in immune response it may be crucial. Dcs precursors were isolated with the use of immunomagnetic beads from BLV-infected and BLV-free cows. From these precursors cultures of monocyte derived dendritic cells (MoDCs) were generated with the use of a cytokine cocktail (IL-4 and GM-CSF). Additionally, parallel DCs from BLV-negative animals were infected in vitro. The level of cytokines: IL-6, IL-10, IL-12(p40), IL-12(p70) was determined in DC cultures: infected in vitro, originating from naturally infected cattle and BLV-free cattle. The investigation showed significant changes in almost all analyzed populations of BLV-infected Dcs. Cytokine profiles of blood MoDCs indicated activation of these groups during infection. In the case of spleen MoDCs and lymph node MoDCs a decrease in production of IL-12(p40) and IL-12(p70) in favour of IL-6 and IL-10 was noted, suggesting promotion of BLV infection development.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2017
• Tom: 20
• Numer: 2
• Opis fizyczny: p.221-231,fig.,ref.

Twórcy

autor

Iwan E.

• Department of Biochemistry, National Veterinary Research Institute, al. Partyzantow 57, 24-100 Pulawy, Poland

autor

Szczotka M.

• Department of Biochemistry, National Veterinary Research Institute, al. Partyzantow 57, 24-100 Pulawy, Poland

autor

Kocki J.

• Department of Clinical Genetics, Medical University, Radziwillowska 11, 20-080 Lublin, Poland

Bibliografia

• Abdi K (2002) IL-12: the role of p40 versus p75. Scand J Immunol 56: 1-11.
• Amills M, Ramiya V, Norimine J, Olmstead CA, Lewin HA (2002) Reduced IL-2 and IL-4 mRNA expression in CD4+ T cells from bovine leukemia virus-infected cows with persistent lymphocytosis. Virology 304: 1-9.
• Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
• Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, Henkart PA (1994) Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A 91: 11811-11815.
• Doménech A, Goyache J, Llames L, Jesús Payá M, Suárez G, Gómez-Lucta E (2000) In vitro infection of cells of the monocytic/macrophage lineage with bovine leukaemia virus. J Gen Virol 81: 109-118.
• Droogmans L, Cludts I, Cleuter Y, Kerkhofs P, Adam E, Willems L, Kettmann R, Burny A (1994) Expression of interleukin 6 receptors and interleukin 6 mRNA by bovine leukaemia virus-induced tumour cells. Cytokine 6: 641-646.
• Flint SJ, Enquist LW, Racaniello VR, Skalka AM (2009) Principles of Virology, 3rd ed., ASM Press, New York.
• Frie MC, Coussens PM (2015) Bovine leukemia virus: a major silent threat to proper immune responses in cattle. Vet Immunol Immunopathol 163: 103-114.
• Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F, Balon H, Bouzar AB, Defoiche J, Burny A, Reichert M, Kettmann R, Willems L (2007) Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 4: 18.
• Heeney JL, Valli PJ, Jacobs RM, Valli VE (1992) Evidence for bovine leukemia virus infection of peripheral blood monocytes and limited antigen expression in bovine lymphoid tissue. Lab Invest 66: 608-617.
• Iwan E, Szczotka M, Kuźmak J (2014) Application of in situ PCR for the detection of bovine leukaemia virus (BLV) infection in dendritic cell cultures. Bull Vet Inst Pulawy 58: 347-352.
• Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW (2008) Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med 14: 429-436.
• Kabeya H, Ohashi K, Onuma M (2001) Host immune responses in the course of bovine leukemia virus infection. J Vet Med Sci 63: 703-708.
• Konnai S, Usui T, Ohashi K, Onuma M (2003) The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR. Vet Microbiol 94: 283-94.
• Lairmore MD (2014) Animal models of bovine leukemia virus and human T-lymphotrophic virus type-1: insights in transmission and pathogenesis. Annu Rev Anim Biosc i 2: 189-208.
• Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014: 149185.
• Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers (Basel) 3: 3856-3893.
• Lucey DR, Clerici M, Shearer GM (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9: 532-562.
• Lundberg P, Splitter GA (2000) Gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host. J Virol 74: 8299-8306.
• Meirom R, Moss S, Brenner J, Heller D, Trainin Z (1997) Levels and role of cytokines in bovine leukemia virus (BLV) infection. Leukemia 11: 219-220.
• Méndez-Samperio P (2010) Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease. Int J Infect Dis 14: e366-71.
• Muller C, Coffey TJ, Koss M, Teifke JP, Langhans W, Werling D (2003) Lack of TNF alpha supports persistence of a plasmid encoding the bovine leukaemia virus in TNF(-/-) mice. Vet Immunol Immunopathol 92: 15-22.
• Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12: 265-277.
• Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
• Pinzon-Charry A, Maxwell T, López JA (2005) Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 83: 451-461.
• Pique C, Jones KS (2012) Pathways of cell-cell transmission of HTLV-1. Front Microbiol 3: 378.
• Pyeon D, Diaz FJ, Splitter GA (2000) Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol 74: 5740-5745.
• Pyeon D, O’Reilly KL, Splitter GA (1996) Increased interleukin- 10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. J Virol 70: 5706-5710.
• Pyeon D, Splitter GA (1998) Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis. J Virol 72: 6917-6921.
• Pyeon D, Splitter GA (1999) Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10. J Virol 73: 8427-8434.
• Stephens SA, Brownlie J, Charleston B, Howard CJ (2003) Differences in cytokine synthesis by the sub-populations of dendritic cells from afferent lymph. Immunology 110: 48-57.
• Stott ML, Thurmond MC, Dunn SJ, Osburn BI, Stott JL (1991) Integrated bovine leukosis proviral DNA in T helper and T cytotoxic/suppressor lymphocytes. J Gen Virol 72: 307-315.
• Svenson U, Gronlund E, Soderstrom I, Sitaram RT, Ljungberg B, Roos G (2013) Telomere length in relation to immunological parameters in patients with renal cell carcinoma. PLoS One 8: e55543.
• Szczotka M, Buzala E, Kubis P, Rulka J (2005) Expression of IL-6 in sheep infected with bovine leukemia virus. Medycyna Weterynaryjna 61: 695-698.
• Szczotka M (2007) The use of flow cytometry for evaluation of gp51 expression in lymphocytes of cattle infected with bovine leukemia virus (BLV). PIWet-PIB, Puławy.
• Tîrziu E, Cenuşe C, Nichita I, Cumpǎnaşoiu C, Mot¸ D, Şereş M (2013) Research on implication of some cytokines in enzootic bovine leukosis. Medicina Veterinara 46: 136-143.
• Trainin Z, Brenner J, Meirom R, Ungar-Waron H (1996) Detrimental effect of bovine leukemia virus (BLV) on the immunological state of cattle. Vet Immunol Immunopathol 54: 293-302.
• Usui T, Konnai S, Ohashi K, Onuma M (2007) Interferon-gamma expression associated with suppression of bovine leukemia virus at the early phase of infection in sheep. Vet Immunol Immunopathol 115: 17-23.
• Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G (2010) Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood 116: 3809-3817.
• Vignali DA, Kuchroo VK (2012) IL-12 Family Cytokines: Immunological Playmakers. Nat Immunol 13: 722-728.
• Wilson EB, Brooks DG (2011) The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol 350: 39-65.
• Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR (2003) Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 95: 1211-1218.
• Yakobson B, Brenner J, Ungar-Waron H, Trainin Z (2000) Cellular immune response cytokine expression during the initial stage of bovine leukemia virus (BLV) infection determines the disease progression to persistent lymphocytosis. Comp Immunol Microbiol Infect Dis 23: 197-208.
• Yakobson B, Brenner J, Ungar-Waron H, Trainin Z (1998) Short-termed expression of interleukin-12 during experimental BLV infection may direct disease progression to persistent lymphocytosis. Vet Immunol Immunopathol 64: 207-218.

Identyfikatory

DOI

10.1515/pjvs-2017-0027